Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms.
about
Famotidine in the management of schizophrenia.Non-cardiac adverse effects of antihistamines (H1-receptor antagonists).metabolic profiling of Parkinson's disease and mild cognitive impairment.A randomized trial of the efficacy and safety of the H3 antagonist ABT-288 in cognitive impairment associated with schizophrenia.Association of histamine N-methyltransferase Thr105Ile polymorphism with Parkinson's disease and schizophrenia in Han Chinese: a case-control study.Histamine and motivation.Schizophrenia shows a unique metabolomics signature in plasmaNormal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditionsPotential enhancing effects of histamine H₁ agonism/H₃ antagonism on working memory assessed by performance and bold response in healthy volunteersHistamine is required for H₃ receptor-mediated alcohol reward inhibition, but not for alcohol consumption or stimulationAltered histamine H3 receptor radioligand binding in post-mortem brain samples from subjects with psychiatric diseases.Day-night differences in neural activation in histaminergic and serotonergic areas with putative projections to the cerebrospinal fluid in a diurnal brain.The histaminergic network in the brain: basic organization and role in disease.Rational Use of Second-Generation Antipsychotics for the Treatment of ICU Delirium.The Histamine H3 Receptor: Structure, Pharmacology, and Function.Histamine H3 Receptor Regulates Sensorimotor Gating and Dopaminergic Signaling in the Striatum.Histamine H1 receptor occupancy by the new-generation antipsychotics olanzapine and quetiapine: a positron emission tomography study in healthy volunteers.Interaction of clozapine with the histamine H3 receptor in rat brainInability to replicate cerebrospinal fluid histamine deficits in the primary hypersomnias: a back to the drawing board moment.A Novel Developmental Role for Dopaminergic Signaling to Specify Hypothalamic Neurotransmitter Identity.Apparent absence of famotidine-antipsychotic drug interactions in patients with chronic schizophrenia.Histamine H3 receptor activation decreases kainate-induced hippocampal gamma oscillations in vitro by action potential desynchronization in pyramidal neurons.Addressing the need for biomarker liquid chromatography/mass spectrometry assays: a protocol for effective method development for the bioanalysis of endogenous compounds in cerebrospinal fluid.Appropriate amino acid mixtures for tryptophan depletion and tyrosine/phenylalanine depletion and the safety of long-term amino acid depletion in humans: reply.N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.The role of the brain histaminergic neuron system in methamphetamine-induced behavioral sensitization in rats.A pharmacogenetic study of risperidone on histamine H3 receptor gene (HRH3) in Chinese Han schizophrenia patients.
P2860
Q33689238-98F4EB0A-7E11-4F88-922F-FC1CE5FFD4B6Q33709789-8DCEA520-B1CB-462F-AB1E-085B8A4DD165Q33835701-D68C24B6-0BE1-4DDC-BCC5-8645CCE6986AQ34322964-E7EF4A2C-CF18-4462-BDC9-ECC870E79981Q35175592-6BD62467-C062-4292-B48A-8468F9B72C65Q36075142-DB86B505-EAA0-4C3D-A31E-044861515B01Q36203421-D15E1448-0CCE-433B-863F-E51A4302F0C7Q36238099-96A5FB5C-6A27-4022-8798-C6B260633DC6Q37151155-C637C5E2-03D3-4F4C-8D77-8A5E7E3A7602Q37151165-C427C043-0535-4098-B2D2-788DE110FD7DQ37230890-3D07BDA5-E757-4D7D-BE73-971E27854B86Q37354422-8FF332E0-343E-4E52-B1B8-8B2695D23D91Q38115678-DB0E6A9B-AF09-40EB-A91A-6734DC6AAE2EQ38512191-FB1E07D6-F397-4C46-AE2A-6B264D58AC44Q38937634-BA3C24B7-EC5C-404A-93C5-011130B25F46Q39946523-DE0D11B7-349E-4195-A491-2666B02F12F3Q40767254-BE3E57AD-78E3-4C01-9835-D126DBC0883DQ42090230-606BDE41-C612-463E-8B4D-67FF0CA42C55Q42325629-F13413EC-5AE8-4DDA-8686-221CF3822092Q42383195-188B630A-F87B-478D-9BF1-B53C3276E25AQ42939760-6B3B3522-894E-4937-B05B-1BB8481271A5Q43161455-11F61C74-925F-4BA0-94E5-92EF33F1F39BQ43483883-4034A00E-9037-4551-AFA2-93C64494A30CQ46166506-2E644EAF-FD0E-49FC-A9C8-4016496405DFQ48441021-490DBDF9-AF19-4BA5-8BDD-57BD889C1B11Q48886526-8A92C67B-8F25-4369-8C04-98AB701A510CQ51864823-965A74C4-891E-4546-9FA1-A95F0E0349D9
P2860
Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Histamine metabolites in cereb ...... tters and ratings of symptoms.
@en
Histamine metabolites in cereb ...... tters and ratings of symptoms.
@nl
type
label
Histamine metabolites in cereb ...... tters and ratings of symptoms.
@en
Histamine metabolites in cereb ...... tters and ratings of symptoms.
@nl
prefLabel
Histamine metabolites in cereb ...... tters and ratings of symptoms.
@en
Histamine metabolites in cereb ...... tters and ratings of symptoms.
@nl
P2093
P921
P1476
Histamine metabolites in cereb ...... tters and ratings of symptoms.
@en
P2093
A M Morrishow
C A Kaufmann
J K Khandelwal
M Linnoila
P304
P356
10.1016/0920-9964(94)00034-6
P407
P577
1995-01-01T00:00:00Z